RemeGen (9995) Schedules Board Meeting on October 30, 2025 to Review Unaudited Third Quarterly Results

Bulletin Express
10/17

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited note in the announcement that they accept no liability for its contents nor for any loss arising from reliance on it.

RemeGen Co., Ltd.* (Stock Code: 9995) has announced that its board of directors will convene a meeting on Thursday, October 30, 2025. The session will consider and approve the company’s unaudited results for the nine months ended September 30, 2025, along with other matters deemed necessary. The announcement was dated October 17, 2025, from Yantai, The People’s Republic of China.

The board is chaired by Mr. Wang Weidong (also an executive director). Executive directors include Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Lin Jian, and Mr. Wen Qingkai. Non-executive directors comprise Dr. Wang Liqiang and Dr. Su Xiaodi. Independent non-executive directors are Mr. Hao Xianjing, Mr. Chen Yunjin, and Mr. Huang Guobin.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10